CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Shah Pritesh Chief Growth Officer | Grant or award | +43,246 | 146,220 | ||
| 2023-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +48,050 | 231,452 | ||
| 2023-03-03 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +3,936 | 235,388 | ||
| 2023-03-03 | Cordova Ashley Chief Financial Officer | Grant or award | +11,808 | 106,815 | ||
| 2023-03-03 | Leonard Frank X President, CNS Cancers US | Grant or award | +11,808 | 69,952 | ||
| 2023-03-03 | Leonard Frank X President, CNS Cancers US | Sale | −2,059 | $77.64 | $160K | 67,893 |
| 2023-03-02 | Burke William Patrick Chief Human Resources Officer | Sale | −281 | $75.28 | $21K | 66,683 |
| 2023-03-02 | Shah Pritesh Chief Growth Officer | Sale | −937 | $75.28 | $71K | 99,038 |
| 2023-03-02 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −1,213 | $75.28 | $91K | 183,402 |
| 2023-03-02 | Cordova Ashley Chief Financial Officer | Sale | −1,055 | $75.28 | $79K | 95,007 |
| 2023-03-02 | Leonard Frank X President, CNS Cancers US | Sale | −844 | $75.28 | $64K | 58,144 |
| 2023-03-02 | Leonard Frank X President, CNS Cancers US | Sale | −3,799 | $75.32 | $286K | 59,296 |
| 2023-03-02 | Leonard Frank X President, CNS Cancers US | Sale | −308 | $76.05 | $23K | 58,988 |
| 2023-03-01 | Leonard Frank X President, CNS Cancers US | Sale | −1,684 | $76.36 | $129K | 63,095 |
| 2023-03-01 | Shah Pritesh Chief Growth Officer | Sale | −1,923 | $76.36 | $147K | 99,975 |
| 2023-03-01 | Cordova Ashley Chief Financial Officer | Sale | −2,198 | $76.36 | $168K | 96,062 |
| 2023-03-01 | Burke William Patrick Chief Human Resources Officer | Sale | −755 | $76.36 | $58K | 66,964 |
| 2023-03-01 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Sale | −2,164 | $76.36 | $165K | 184,615 |
| 2023-02-28 | Leonard Frank X President, CNS Cancers US | Grant or award | +18,621 | 64,779 | ||
| 2023-02-28 | Leonard Frank X President, CNS Cancers US | Grant or award · Options to Buy Ordinary Shares | +30,971 | $76.97 | $2.4M | 30,971 |
Page 15 of 20 · 399 trades